Creative Medical Technology Holdings, Inc.

CELZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $4.8K $0 $0 $0 $0 $0 $0 $0
Cost of Revenue $8.0K $0
Gross Profit $-3.2K $0
Gross Margin -66.7%
Operating Expenses
Research & Development $260.1K $85.3K
SG&A Expense $898.5K $665.0K
Operating Income $-1.2M $-759.7K $-20.8K $-19.4K $-20.1K $-20.1K $-19.8K $-14.3K
Operating Margin -24,537.6%
Interest Expense $377.6K $6.4K
Pretax Income $-2.7M $-24.1K $-17.3K
Income Tax Expense $0 $0 $0
Net Income $-2.7M $-766.1K $-30.8K $-28.0K $-27.3K $-25.6K $-24.1K $-17.3K
Net Margin -55,398.1%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 2.07B 1.89B 326.0M 326.0M 326.0M 326.0M 326.0M
Shares Outstanding (Diluted) 2.07B 1.89B 326.0M 326.0M 326.0M 326.0M 326.0M 326.0M
Dividends Per Share
← Newer Page 2 of 2 Older →